Aslanian M, Sharp C, Rozanski E, De Laforcade A, Rishniw M, Brooks M Clinical Outcome after Diagnosis of Hemophilia A in Dogs. J Am Vet Med Assoc. 2014; 245:(6)677-83
Borchers A Hemostatic Drugs. Chapter 170, 893, 2nd Edition. : Elsevier; 2015
Brooks M, Barnas J, Fremont J, Ray J Cosegregation of a Factor VIII Microsatellite Marker with Mild Hemophilia A in Golden Retriever Dogs. J Vet Intern Med. 2005; 19:205-10
Callan M, Haskins M, Wang P, Zhou S, High K, Arruda V Successful Phenotype Improvement Following Gene Therapy for Severe Hemophilia A in Privately Owned Dogs. Plos One. 2016; 11:(3)
Connelly S., Mount J., Mauser A Complete Short-Term Correction of Canine Hemophilia A by In Vivo Gene Therapy. Blood. 1996; 88:(10)3846-53
Du L, Nurden P, Nurden A Platelet-Targeted Gene Therapy with Human Factor VIII Establishes Haemostasis in Dogs with Haemophilia A. Nature Communications. 2013; 4
Dunning MD, Averis GF, Pattinson H, Targett M, Cade S, Herrtage ME Haemophilia A (Factor VIII Deficiency in a Litter of Weimaraners. J Small Anim Pract. 2009; 50:357-9
Finn J, Ozelo M, Sabatino D Eradication of Neutralizing Antibodies to Factor VIII in Canine Hemophilia A after Liver Gene Therapy. Blood. 2010; 116:(26)5842-8
Garcia L, Couto C, Brooks M Postoperative Bleeding in Retired Greyhounds. J Vet Intern Med. 2008; 22:525-33
Gavazza A, Lubas G, Trotta M, Caldin M Hemophilia A in a Belgian Shepherd Malinois Dog: Case Report. Res Vet Sci. 2014; 97:(1)96-8
Gerber B, Taboada J, Lothrop C Determination of Normal Values Using an Automated Coagulation Timer for Activated Coagulation Time and its Application in Dogs with Hemophilia. J Vet Intern Med. 1999; 13:433-6
Heseltine J, Panciera D, Troy G, Monroe W, Brooks M, Feldman B Effect of Levothroxine Administration on Hemostatic Analytes in Doberman Pinschers with Von Willebrand Disease. J Vet Intern Med. 2005; 19:523-7
Leenerts HM, Koehler J, Neil R Nursing Care Models Increase care Quality While Reducing Costs. Journal of the Association of Nurses in AIDS Care. 1996; 7:(4)37-49
Littlewood J Disorders of Secondary Haemostasis. Chapter 13. In: Day M, Mackin A, Littlewood J : BSAVA; 2012
Mansell P, Parry B Changes in Factor VIII: Coagulant Activity and Von Willebrand Factor Antigen Concentration after Subcutaneous Injection of Desmopressin in Dogs with Mild Hemophilia A. J Vet Intern Med. 1991; 5:(3)191-4
Margaritis P, Roy E, Aljamali M Successful Treatment of Canine Hemophilia by Continuous Expression of Canine FVIIa. Blood. 2009; 113:(16)3682-9
Mathews K, Scott H, Abrams-Ogg A Transfusion of Blood Products. Chapter 96, 668, 2nd Edition. In: Mathews K : Lifelearn; 2006
Nelson D, Welsh P Using thr Ability Model to Design and Implement a patient Care Plan. The Veterinary Nurse. 2015; 6:(3)141-9
O'Kelley B, Whelan M, Brooks M Factor VIII Inhibitors Complicating Treatment of Postoperative Bleeding in a Dog with Haemophilia A. J Vet Emerg Crit Care. 2009; 19:(4)381-5
Orpet H, Jeffery A Moving Towards a More Holistic Approach. Veterinary Nursing Journal. 2006; 26:(5)19-22
Orpet H, Jeffery A Implementing the Ability Model.London: Royal Veterinary College; 2007
Rose L, Dunn M, Bedard C Effect of Canine Hyperadrenocorticism on Coagulation Parameters. J Vet Intern Med. 2013; 27:207-11
Stokol T, Parry B Efficacy of Fresh-Frozen Plasma and Cryoprecipitate in Dogs with Von Willebrand's Disease or Hemophilia A. J Vet Intern Med. 1998; 12:(2)84-92